Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
Press Releases
October 28, 2024

Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI

DANVERS, Mass., Oct. 28, 2024 /PRNewswire/ -- Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ECP™, a

bradford

The Bradford Era

Local & Social